Published in Oncotarget on July 26, 2016
In Vivo Follow-up of Brain Tumor Growth via Bioluminescence Imaging and Fluorescence Tomography. Int J Mol Sci (2016) 0.75
In Vivo magnetic resonance imaging of xenografted tumors using FTH1 reporter gene expression controlled by a tet-on switch. Oncotarget (2016) 0.75
Amine Landscaping to Maximize Protein-Dye Fluorescence and Ultrastable Protein-Ligand Interaction. Cell Chem Biol (2017) 0.75
Inflammation and cancer. Nature (2002) 53.78
Cancer-related inflammation. Nature (2008) 34.21
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (2001) 22.06
A guide to choosing fluorescent proteins. Nat Methods (2005) 18.55
In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol (2004) 17.47
Semiconductor nanocrystals as fluorescent biological labels. Science (1998) 16.68
Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater (2005) 12.97
Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol (2001) 11.41
Proliferation, cell cycle and apoptosis in cancer. Nature (2001) 9.57
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood (1994) 9.10
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol (1999) 8.46
Apoptosis: a link between cancer genetics and chemotherapy. Cell (2002) 7.86
G-protein-coupled receptors and cancer. Nat Rev Cancer (2007) 6.80
Apoptosis. Its significance in cancer and cancer therapy. Cancer (1994) 6.71
A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect (2006) 6.66
The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer (2001) 5.96
Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng (2002) 5.90
Optical properties of biological tissues: a review. Phys Med Biol (2013) 5.48
Quantum dots versus organic dyes as fluorescent labels. Nat Methods (2008) 5.36
Links between metabolism and cancer. Genes Dev (2012) 5.27
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med (1998) 5.14
Epidermal growth factor. J Biol Chem (1990) 4.79
Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J Histochem Cytochem (1999) 4.71
The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol (1999) 4.65
Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (2008) 4.17
Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology (2008) 4.15
Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol (2002) 3.73
Fluorescence molecular imaging. Annu Rev Biomed Eng (2006) 3.70
Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer (2005) 3.62
HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clin Breast Cancer (2004) 3.50
Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol (2005) 3.34
G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov (2011) 3.31
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res (2007) 3.25
The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol (2011) 3.24
Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging. Nat Chem Biol (2006) 3.22
A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo. Cancer Res (2003) 3.09
Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt (2007) 3.04
Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res (2007) 3.03
microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide. J Nucl Med (2005) 2.96
COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer (2000) 2.94
Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development. J Biomed Opt (2005) 2.94
Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Opt Express (2007) 2.84
Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat Chem Biol (2007) 2.80
The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene (2009) 2.72
The fluorescent protein palette: tools for cellular imaging. Chem Soc Rev (2009) 2.69
Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med (2011) 2.60
It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging (2002) 2.58
In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res (2009) 2.51
In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res (2004) 2.46
Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg (2008) 2.41
Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res (2003) 2.25
A common structural motif incorporating a cystine knot and a triple-stranded beta-sheet in toxic and inhibitory polypeptides. Protein Sci (1994) 2.24
Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology (2001) 2.24
Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem (2002) 2.21
Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation (2007) 2.20
In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res (2007) 2.19
A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging (2012) 2.18
Biological consequences of tumor hypoxia. Semin Oncol (2001) 2.11
Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol Sci (2007) 2.07
In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green. Med Phys (2003) 2.02
Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem (1998) 1.99
Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl Med Biol (2006) 1.98
Real-time measurements of dissolved oxygen inside live cells by organically modified silicate fluorescent nanosensors. Anal Chem (2004) 1.97
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res (2008) 1.96
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J Control Release (2012) 1.95
Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small (2009) 1.93
Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat Med (2009) 1.90
The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis (1992) 1.86
Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia (2002) 1.85
A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts. Int J Cancer (2005) 1.79
Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin Cancer Res (2007) 1.76
Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug Chem (2006) 1.75
Fluorescent labeling of biomolecules with organic probes. Chem Rev (2009) 1.74
Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression. Proc Natl Acad Sci U S A (2005) 1.72
Magneto/optical annexin V, a multimodal protein. Bioconjug Chem (2004) 1.71
Nanoparticle imaging of integrins on tumor cells. Neoplasia (2006) 1.70
Tumor cell metabolism imaging. J Nucl Med (2008) 1.67
Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer. Clin Cancer Res (2008) 1.66
On the nature of the multivalency effect: a thermodynamic model. J Am Chem Soc (2003) 1.64
Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med (2011) 1.62
Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol (2010) 1.61
A role for ion channels in glioma cell invasion. Neuron Glia Biol (2006) 1.57
Caspases and cancer. Cell Death Differ (2011) 1.56
In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies. Mol Cancer Ther (2009) 1.55
Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth. PLoS One (2008) 1.55
Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer? Prostate (2007) 1.55
Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots. Eur J Nucl Med Mol Imaging (2008) 1.55
Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? Biochim Biophys Acta (2009) 1.55
Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. Cancer (2011) 1.55
Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res (2003) 1.55
First human Cerenkography. J Biomed Opt (2013) 1.53
Human Lymphatic Architecture and Dynamic Transport Imaged Using Near-infrared Fluorescence. Transl Oncol (2010) 1.53
Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol (2012) 1.52
Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts. Mol Cancer Ther (2007) 1.52
Inhibiting hypoxia-inducible factor 1 for cancer therapy. Mol Cancer Res (2006) 1.51
Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging. Acta Radiol (2009) 1.49
Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells. J Mol Biol (2007) 1.48
Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers. Mol Imaging Biol (2006) 1.46
Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol (2006) 1.45
Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases. Mol Pharm (2009) 1.42